Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722206 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Electronic (PDF)Add to Basket
Site LicenseAdd to Basket
EnterprisewideAdd to Basket



Analytical Tool - Leukemia Therapeutics & Competitive Insights
Bioseeker, May 2007


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

'Analytical Tool - Leukemia Therapeutics & Competitive Insights' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in leukemia R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - Leukemia - A Therapeutic & Competitive Insight and Leukemia Drug Pipeline Update 2007-.

The Package Includes:

A progress analysis on current and emerging drugs
Information on most companies active in leukemia R&D
Information on key industry related leukemia projects
Data from most important clinical trials
Information on early developmental stage projects
Possibility of performing advanced searches suited to your individual needs
This Tool will Assist You in:

Tracking cutting edge companies, therapies and new technologies
Rapid identification of partners & competitors
Laying down a comprehensive framework for further analysis of the field
Producing presentations surrounding the development of leukemia therapeutics
Identifying emerging leukemia products & key areas of pharmaceutical R&D
-BioSeekers CD-ROM searchable database reflects the most recent advances in the field of leukemia development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker Group CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group’s CD-ROM searchable databases give better overview and specific search capabilities.




Customers who bought this item also bought

Leukemia - A Therapeutic & Competitive Insight

Analytical Tool - Hematological Cancers

Pipeline Insight: Hematological Malignancies - Pursuit For The Next Blockbuster Intensifies

Hematological Malignancies: Companies Target Niche Indications to Facilitate Market Entry

Global Pipeline Review & Analysis of Hematological Malignancies

Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Drug Pipeline Report

Acute Myeloid Leukemia: Cytarabine Here to Stay

Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report

Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus on Leukemias and Lymphomas

Hematological Cancers - A Therapeutic & Competitive Insight

Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use

Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia



Top of page


   All rights reserved. � Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds